Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	448	-	-	-
Enterprise Value	290	-	-	-
Debt / Equity Ratio	0.06	0.06	0.31	-
Quick Ratio	14.16	14.16	4.79	10.01
Current Ratio	14.49	14.49	4.88	10.16
Return on Equity (ROE)	-61.44%	-61.44%	-83.45%	-
Return on Assets (ROA)	-37.10%	-37.10%	-45.16%	-
Return on Capital (ROIC)	-39.90%	-39.90%	-50.84%	-
Buyback Yield / Dilution	-31.56%	-13.80%	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q